As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.
10 Analysts have issued a Adagene Inc - ADR forecast:
10 Analysts have issued a Adagene Inc - ADR forecast:
Dec '24 |
+/-
%
|
||
Revenue | 0.10 0.10 |
99%
99%
|
|
Gross Profit | - - |
-
|
|
EBITDA | -35 -35 |
-
|
EBIT (Operating Income) EBIT | -36 -36 |
52%
52%
|
Net Profit | -33 -33 |
76%
76%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Adagene, Inc. engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.
Head office | Cayman Islands |
CEO | Peizhi Luo |
Employees | 138 |
Founded | 2011 |
Website | www.adagene.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.